1-15 of 324
GPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations
DermConsultGPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations
Andrew Dorizas
Identifying GPP: Clinical Clues Across Phases
DermConsultIdentifying GPP: Clinical Clues Across Phases
Shannon Trotter, DO, FAOCD, FAAD
Shannon Trotter, DO, FAOCD, FAAD
Shannon Trotter, DO, FAOCD, FAAD
Moving GPP Care Forward: From Awareness to Action
DermConsultMoving GPP Care Forward: From Awareness to Action
Shannon Trotter, DO, FAOCD, FAAD
Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Project Oncology®Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Jason Starr, DO
- advertisement
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeFamilial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD
Nivedita Patni, MD
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease
Brian P. McDonough, MD, FAAFP
Doreen Addrizzo-Harris, MD
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Clinician's RoundtableEmerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Alexandria May, PharmD, BCPS
David E. Griffith, MD
Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Project Oncology®Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Alexandria May, PharmD, BCPS
Prithviraj Bose, MD
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
- advertisement
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Evaluating Port-Wine Capillary Malformations in Children
On the Frontlines of Pediatric Skin HealthEvaluating Port-Wine Capillary Malformations in Children
Kristen Kelly, MD
Alexandria May, PharmD, BCPS
